Political VIPs turned out for a tape-cutting ceremony at Amazon’s new research and development facility in the Saxon city of Dresden.
Location / R&D
The place to be for young entrepreneurs into 5G right now is Munich’s Wayra 5G Tech Lab, a project created by the Telefónica/O2’s in-house start up accelerator, Wayra Germany.
The German co-developer of one of the world’s leading coronavirus vaccines, BioNTech, is training its sights on other infectious diseases, including malaria. In late July, the company from the southwestern city of Mainz launched its “malaria project” that aims produce a safe and effective vaccine by the end of 2022.
A private company, a respected university and the police in the eastern regional state of Saxony-Anhalt have come up with a digital 3D analysis system to help emergency responders better deal with crisis situations such as terrorist attacks, fires and natural catastrophes.
One of Germany’s top scientific institutes – the Helmholtz Association – has come in second around the world in the 2021 Rising Stars Index of increased research productivity.
Rare but serious cases of blood clotting in people inoculated by the vector vaccines produced by AstraZeneca and Johnson&Johnson have been one obstacle to the international immunization campaigns against Covid-19.
Three years from now, when NASA’s Orion spacecraft heads for the moon, technology made in northern Germany will help it get there.
The German government has announced a massive five-year investment intended to bolster competitive quantum computer technology and create a surrounding eco-system for users.
Scientists know that around 19 percent of those infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes Covid-19, contract a severe case of the disease. But it’s been difficult to predict which patients are most at risk of life-threatening illness.
Messenger RNA (mRNA) is at the heart of the world’s most effective anti-corona vaccines and has also shown great promise in combatting cancer and other diseases. Now scientists at Germany’s Research Center Jülich, working with pharmaceutical company AstraZeneca, have discovered how it can be better administered under the skin.